Literature DB >> 19828264

Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives.

Maxine L Stitzer1, Tiffany Polk, Sarah Bowles, Thomas Kosten.   

Abstract

Vaccines represent a new and promising avenue of treatment for drug abuse but pose new medication adherence challenges due to prolonged and widely spaced administration schedules. This study examined effects of prize-based incentives on retention and medication adherence among 26 cocaine users involved in a 6-month hepatitis B vaccination series. Participants could meet with research staff weekly for 24 weeks and receive 7 injections containing either the Hepatitis B vaccine or a placebo. All participants received $10 at each weekly visit (maximum of $240). Those randomly assigned to the incentive program received additional monetary payments on an escalating schedule for attendance at weekly monitoring and vaccination visits with maximum possible earnings of $751. Group attendance diverged after study week 8 with attendance better sustained in the incentive than control group (group by time interaction, p=.035). Overall percent of weekly sessions attended was 82% for incentive versus 64% for control (p=.139). Receiving all scheduled injections were 77% of incentive versus 46% of control participants (p=.107). A significantly larger percentage (74% versus 51%; p=.016) of injections were received by incentive versus control participants on the originally scheduled day. Results suggest that monetary incentives can successfully motivate drug users to attend sessions regularly and to receive injected medications in a more reliable and timely manner than may be seen under usual care procedures. Thus, incentives may be useful for addressing adherence and allowing participants to reap the full benefits of newly developed medications. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828264      PMCID: PMC2815120          DOI: 10.1016/j.drugalcdep.2009.09.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  19 in total

1.  Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention.

Authors:  M O Rigsby; M I Rosen; J E Beauvais; J A Cramer; P M Rainey; S S O'Malley; K D Dieckhaus; B J Rounsaville
Journal:  J Gen Intern Med       Date:  2000-12       Impact factor: 5.128

2.  Monetary versus nonmonetary incentives for TB skin test reading among drug users.

Authors:  C K Malotte; J R Hollingshead; F Rhodes
Journal:  Am J Prev Med       Date:  1999-04       Impact factor: 5.043

3.  Improvement in naltrexone treatment compliance with contingency management.

Authors:  K L Preston; K Silverman; A Umbricht; A DeJesus; I D Montoya; C R Schuster
Journal:  Drug Alcohol Depend       Date:  1999-04-01       Impact factor: 4.492

Review 4.  Opioid dependence treatment, including buprenorphine/naloxone.

Authors:  Dennis W Raisch; Carol L Fye; Kathy D Boardman; Mike R Sather
Journal:  Ann Pharmacother       Date:  2002-02       Impact factor: 3.154

5.  Evaluation of an injection depot formulation of buprenorphine: placebo comparison.

Authors:  Stacey C Sigmon; Conrad J Wong; Allison L Chausmer; Ira A Liebson; George E Bigelow
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

6.  Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.

Authors:  Nancy M Petry; Bonnie Martin
Journal:  J Consult Clin Psychol       Date:  2002-04

7.  Vaccine pharmacotherapy for the treatment of cocaine dependence.

Authors:  Bridget A Martell; Ellen Mitchell; James Poling; Kishor Gonsai; Thomas R Kosten
Journal:  Biol Psychiatry       Date:  2005-07-15       Impact factor: 13.382

Review 8.  Vaccines for cocaine abuse.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Thomas R Kosten
Journal:  Hum Vaccin       Date:  2009-04-20

Review 9.  Therapeutic vaccines for substance dependence.

Authors:  Margaret Haney; Thomas R Kosten
Journal:  Expert Rev Vaccines       Date:  2004-02       Impact factor: 5.217

10.  A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users.

Authors:  Karen H Seal; Alex H Kral; Jennifer Lorvick; Alex McNees; Lauren Gee; Brian R Edlin
Journal:  Drug Alcohol Depend       Date:  2003-08-20       Impact factor: 4.492

View more
  23 in total

Review 1.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 2.  Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.

Authors:  Evan S Herrmann; Alexis K Matusiewicz; Maxine L Stitzer; Stephen T Higgins; Stacey C Sigmon; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2016-06-24

3.  Financial reinforcers for improving medication adherence: findings from a meta-analysis.

Authors:  Nancy M Petry; Carla J Rash; Shannon Byrne; Shehryar Ashraf; William B White
Journal:  Am J Med       Date:  2012-07-14       Impact factor: 4.965

4.  The concept of pharmacologic cocaine interception as a treatment for drug abuse.

Authors:  Yang Gao; Frank M Orson; Berma Kinsey; Tom Kosten; Stephen Brimijoin
Journal:  Chem Biol Interact       Date:  2010-02-26       Impact factor: 5.192

5.  Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.

Authors:  Jean B Nachega; Olalekan A Uthman; Carlos del Rio; Michael J Mugavero; Helen Rees; Edward J Mills
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

6.  Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.

Authors:  A Kathleen Burlew; Jerren C Weekes; La'Trice Montgomery; Daniel J Feaster; Michael S Robbins; Carmen L Rosa; Lesia M Ruglass; Kamilla L Venner; Li-Tzy Wu
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

7.  Initial abstinence status and contingency management treatment outcomes: does race matter?

Authors:  LaTrice Montgomery; Kathleen M Carroll; Nancy M Petry
Journal:  J Consult Clin Psychol       Date:  2015-03-23

8.  Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users.

Authors:  Maxine Stitzer; Donald Calsyn; Timothy Matheson; James Sorensen; Lauren Gooden; Lisa Metsch
Journal:  J Subst Abuse Treat       Date:  2016-08-28

Review 9.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

10.  Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call.

Authors:  Jean B Nachega; Olalekan A Uthman; Edward J Mills; Thomas C Quinn
Journal:  J AIDS Clin Res       Date:  2013-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.